Archived articles

Health

COVID-19
Study: Inflammation, not the virus itself, causes COVID-19-related loss of smell
Published April 12, 2022
New research suggests the virus does not infect the nerves of the olfactory bulb but causes inflammation of the tissue, reducing the number of nerves able to transmit signals to the brain
Health
Johns Hopkins researchers identify potential window for treating ALS
Published April 8, 2022
A cell type called astrocytes may contribute to motor neuron death during ALS progression, offering a treatment target for the degenerative disease
Cardiac health
AI predicts if and when someone will experience cardiac arrest
Published April 7, 2022
An algorithm built to assess scar patterns in patient heart tissue can predict potentially life-threatening arrhythmias more accurately than doctors can
Mental health
Incarcerating child sexual abusers topped $5.4 billion in 2021
Published April 5, 2022
The findings highlight financial toll of not preventing child sexual abuse, says researcher Elizabeth Letourneau
Public health
New center merges gun violence research, policy, advocacy
Published March 30, 2022
Newly merged center to combine rigorous scientific research with public-policy advocacy expertise
Mental health
A pandemic test of teenage resilience
Published March 30, 2022
The COVID-19 pandemic has provided some eye-opening lessons on how to improve teen wellbeing and there are reasons to be hopeful for the future, Johns Hopkins experts say
Cancer research
FDA approves new immunotherapy treatment regimen for melanoma patients
Published March 25, 2022
The treatment was developed and studied by researchers at Johns Hopkins and targets aggressive forms of skin cancer
COVID-19
Chemical found in leafy greens slows growth of COVID-19, other viruses
Published March 25, 2022
Sulforaphane could help prevent and treat illnesses caused by coronaviruses, including COVID-19
Virtual assistant
Chatbots battle COVID-19 vaccine hesitancy
Published March 24, 2022
Researchers at Johns Hopkins had already been developing chatbots to combat vaccine misinformation when the coronavirus pandemic arrived, giving their work greater urgency
Q+A
What to know about omicron subvariant BA.2
Published March 23, 2022
Even as BA.2 and "deltacron" set off feelings of panic or exhaustion, vaccinations and boosters continue to provide the best protection against severe disease, says Johns Hopkins immunologist Andy Pekosz